omidubicel
GAMIDA CELL
['bet', '220,mm,001']
congress #ash22 | discusses clinical outcomes with omidubicel vs other allohct donor sources. rates of grade ii-iv acute #gvhd over the first 100 days post allohct were omidubicel 60% vs 32-43% for other sources. but gr iii-iv agvhd &amp; cgvhd were comparable #bmtsm 
A global online platform providing latest treatment options and medical information in graft-versus-host disease (GvHD). #gvhd